Drug Trial Radar · NCT02261493
A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides
Last checked: Nov 20, 2026Latest source record: Jul 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
787
Actual
Start
Oct 27, 2014
Primary completion
Jun 3, 2015
Study completion Apr 20, 2016
Sponsor
- Lead sponsor
- AllerganAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Oct 10, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial rhytides (forehead lines, glabellar lines, lateral canthal lines \[crow's feet lines\]).
Conditions
- Facial Rhytides
- Glabellar Rhytides
Interventions
OnabotulinumtoxinABiological
OnabotulinumtoxinA injected into the protocol-specified areas. Subjects will receive at least 1 and up to 3 treatments.
Normal SalineDrug
Placebo (normal saline) injected into the protocol-specified areas on Day 1.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With ≥2-Grade Improvement From Baseline on Both the Investigator's and Subject's Facial Wrinkle Scale (FWS) Ratings of Forehead Line Severity at Maximum Eyebrow ElevationTime frame: Baseline, Day 30
Locations
24 sites in 4 countries. Site status is shown where the registry gives one.
The Petrus Center for Aesthetic
Little Rock, Arkansas
Westside Aesthetics
Los Angeles, California
Eye Research Foundation
Newport Beach, California
Steve Yoelin, MD Medical Associates, Inc.
Newport Beach, California
Baumann Cosmetic & Research Institute
Miami, Florida
Saint Louis University
St Louis, Missouri
The Center For Dermatology Cosmetic and Laser Surgery
Mount Kisco, New York
Tennessee Clinical Research Center
Nashville, Tennessee
The Center for Skin Research
Houston, Texas
Premier Clinical Research
Spokane, Washington
Aalst Dermatology Clinic
Aalst, Belgium
UZ Brussel
Jette, Belgium
Medical Skin Care - Sint-Truiden
Limbourg, Belgium
Rosenpark Research
Darmstadt, Germany
Hautzentrum Koeln (Cologne Dermatology)
Köln Nordrhein-Westfalen, Germany
Hautok und hautok-cosmetics
München, Germany
Praxisgemeinschaft Theatiner46
München, Germany
Hautzentrum am Starnberger See GmbH
Starnberg, Germany
CentroDerm Study Center
Wuppertal, Germany
Shakespeare House Health Centre, General Practice
Basingstoke, United Kingdom
Medizen Clinic
Birmingham, United Kingdom
The Bosham Clinic
Chichester, United Kingdom
Waverlery Medical Practice
Coatbridge, United Kingdom
The Gatehouse
Whitegate, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.